Granules India gains key FDA approval for Unit V facility, marking major compliance milestone

Granules India gains key FDA approval for Unit V facility, marking major compliance milestone

Hyderabad-based Granules India Limited has achieved a significant regulatory milestone, securing an Establishment Inspection Report (EIR) with a “No Action Indicated” (NAI) status from the U.S. Food and Drug Administration (FDA) for its Unit V facility in Jawaharlal Nehru Pharma City, Andhra Pradesh. The pharmaceutical firm received the EIR following a comprehensive inspection held in […]

Glenmark Life Sciences’ Q1FY25 results shock industry with 9.7% revenue surge

Glenmark Life Sciences’ Q1FY25 results shock industry with 9.7% revenue surge

Glenmark Life Sciences Limited (BSE: 543322, NSE: GLS), a prominent player in the pharmaceutical industry, has announced impressive financial results for the quarter ended June 30, 2024. The company’s revenue surged by 9.7% quarter-on-quarter (QoQ), reaching ₹5,886 million. This growth reflects a solid 1.8% increase year-on-year (YoY), underlining Glenmark Life Sciences’ strong performance amidst challenging […]